A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

Clinical trial NCT03139487 · UNKNOWN

Trial details

NCT number: NCT03139487
Sponsor: Asan Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cancer-associated Thrombosis Esophageal Cancer Stomach Cancer Hepatocellular Carcinoma Pancreatic Cancer Duodenal Cancer Esophagogastric Junction Cancer Malignant Gastrointestinal Stromal Tumor Ampulla of Vater Cancer Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)

Start date: 2017-08-07
Primary completion: 2021-09-30
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.